Table 1.
Clinico-pathological characteristics of ovarian cancer patients
| Clinico-pathologic characteristics | n (%) |
|---|---|
| Ethnicity | |
| Caucasian | 95 (44.8) |
| Asian | 81 (38.2) |
| African-American | 11 (5.2) |
| Missing | 25 (11.8) |
| Cases origin | |
| JHMI | 128 (60.4) |
| Treated at JHMI | 112 (87.5) |
| Consults | 16 (12.5) |
| NTUH | 84 (39.6) |
| Tumor | |
| Primary | 174 (82.1) |
| Recurrence | 20 (9.4) |
| Primary and recurrence | 7 (3.3) |
| Not known | 11 (5.2) |
| Histotype | |
| HGSC | 99 (46.7) |
| CCC | 56 (26.4) |
| EMC | 31 (14.6) |
| LGSC | 26 (12.3) |
| Stage of primary | |
| Stage I | 61 (28.8) |
| Stage II | 11 (5.2) |
| Stage III | 98 (46.2) |
| Stage IV | 22 (10.4) |
| Missing | 20 (9.4) |
Abbreviations: CCC, clear cell carcinoma; EMC endometrioid carcinoma; HGSC, high-grade serous carcinoma; JHMI, Johns Hopkins Medical Institutions; LGSC, low grade serous carcinoma; n, number of cases; NTUH, National Taiwan University Hospital.